SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-320145
Filing Date
2020-12-17
Accepted
2020-12-17 17:03:16
Documents
15
Period of Report
2020-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d15397d8k.htm   iXBRL 8-K 29337
2 EX-1.1 d15397dex11.htm EX-1.1 179198
3 EX-5.1 d15397dex51.htm EX-5.1 9748
7 GRAPHIC g15397g08a80.jpg GRAPHIC 3396
  Complete submission text file 0001193125-20-320145.txt   397277

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA advm-20201217.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20201217_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20201217_pre.xml EX-101.PRE 10951
8 EXTRACTED XBRL INSTANCE DOCUMENT d15397d8k_htm.xml XML 3214
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 201396836
SIC: 2836 Biological Products, (No Diagnostic Substances)